Prostate Cancer
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study.
January 10, 2023
The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence.
January 10, 2023
Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort.
January 10, 2023
Clinician interest in clinical decision support for PSA-based prostate cancer screening.
January 10, 2023
Technical note: Investigating the suitability of existing facilities for a new Lu-177 prostate-specific membrane antigen therapy program.
January 6, 2023
Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
January 6, 2023
Concurrent prognostic utility of lymph node count and lymph node density for men with pathological node-positive prostate cancer.
January 6, 2023
Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations.
January 6, 2023
Association of Androgen Deprivation Therapy with Metabolic Disease in Prostate Cancer Patients: An Updated Meta-Analysis
January 5, 2023